This phase 3 trial tests whether adding lurbinectedin to standard doxorubicin chemotherapy helps people with metastatic leiomyosarcoma live longer without their cancer growing. About 469 adults who have not had prior treatment for advanced disease are being studied. The main goal…
Phase: PHASE3 • Sponsor: PharmaMar • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC